# Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans

> **NCT01056549** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 15 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** exenatide

## Key facts

- **NCT ID:** NCT01056549
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056549, "Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01056549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*